Make an enquiry
Refer a patient
Pay my bill
0808 304 2332

We noticed you are on our UK page. Want to switch regions? Choose from the options:

AU
ES
GenesisCare - logo
Patients
Find a centre
Find a doctor
0808 304 2332
Make an enquiry
Refer a patient
Pay my bill

We noticed you are on our UK page. Want to switch regions? Choose from the options:

AU
ES
Find a centre
Find a doctor
0808 304 2332

Cancer

Cancer
2025-08-07T00:00:00.000+01:00
Ongoing

ARTEMIDE-Lung04

ARTEMIDE-Lung04
Haematology

Trial overview

Disease

Lung Cancer

Sponsor

Astra Zeneca

Description

A Phase III, Randomized, Double-blind, Multicenter, Global Study of Rilvegostomig or Pembrolizumab Monotherapy for the First-line Treatment of Patients with PD-L1-high Metastatic Non-small Cell Lung Cancer (ARTEMIDE-Lung04)

Study details

For detailed information on this trial, please click here

Trial status

Due to open October 2025

Principal Investigator

Dr Omar Khan

Location

Oxford

Oxford :::